What are Entera Bio Ltd's key financial statements?

According to the latest financial statement (Form-10K), Entera Bio Ltd has a total asset of $0, Net loss of $0

What are the key financial ratios for ENTX?

Entera Bio Ltd's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Entera Bio Ltd's revenue broken down by segment or geography?

Entera Bio Ltd largest revenue segment is Oral Tablet Formats of Peptides, at a revenue of 42,000 in the most earnings release.For geography, Israel is the primary market for Entera Bio Ltd, at a revenue of 42,000.

Is Entera Bio Ltd profitable?

no, according to the latest financial statements, Entera Bio Ltd has a net loss of $0

Does Entera Bio Ltd have any liabilities?

no, Entera Bio Ltd has liability of 0

How many outstanding shares for Entera Bio Ltd?

Entera Bio Ltd has a total outstanding shares of 0

ENTX Financials: Entera Bio Ltd AI Analysis



Financials

ENTX Financial

Entera Bio Ltd

$1.3

-5.1%

$-0.07

At close: May 08, 16:00:00 GMT-4

$1.3

Post-market: May 08, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$1.37

Open

$1.29

Day's Range

$1.28 - $1.35

52 week range

$0.91 - $3.22

Volume

123.9K

Avg.Volume

213.8K

Dividend yield

EPS (TTM)

-0.25

Market Cap

$70.7M

What is ENTX?

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. The firm developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.

Features

Markets

News

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Selling, General & Admin	5	1	1	1	1	1
Research & Development	6	1	1	1	1	1
Operating Expenses	11	3	3	2	2	2
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-11	-3	-3	-2	-2	-2
Income Tax Expense	--	--	--	--	--	0
Net Income	-11	-3	-3	-2	-2	-2
Net Income Growth	56.99%	50%	0%	0%	--	100%
Shares Outstanding (Diluted)	47.27	47.27	47.08	46.83	43.37	39.11
Shares Change (YoY)	21%	21%	25%	26%	--	32%
EPS (Diluted)	-0.24	-0.06	-0.06	-0.05	-0.05	-0.06
EPS Growth	25%	6%	-15%	-2%	--	-11%
Free Cash Flow	-7	-1	-2	-1	-1	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-11	-3	-3	-2	-2	-2
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-11	-3	-3	-2	-2	-2
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	0%

Entera Bio Ltd (ENTX) Financial

ENTX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is ENTX?

Entera Bio Ltd (ENTX) Financial

ENTX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is ENTX?

ENTX Income

Follow-Up Questions

What are Entera Bio Ltd's key financial statements?

What are the key financial ratios for ENTX?

How is Entera Bio Ltd's revenue broken down by segment or geography?

Is Entera Bio Ltd profitable?

Does Entera Bio Ltd have any liabilities?

How many outstanding shares for Entera Bio Ltd?